Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $174K 680 sh |
| Nov 2, 2026 traded Oct 30, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $96K 360 sh | Nov 2, 2026 traded Oct 29, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $135K 536 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 10 | Ring ChristineChief Legal Officer |  NRIXNurix Therapeutics, Inc.Option exercise | M | — 3,573 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 10 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 2,859 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 10 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 2,859 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 10 | Stumpf MatthewChief Financial Officer (CFO) | APPAppLovin Corp Grant or award | A | — 54.9K sh | Nov 2, 2026 traded Oct 29, 2026 |
| 10 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,750 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Schultz Leigh AnnDirector |  SHENSHENANDOAH TELECOMMUNICATIONS CO/VA/Grant or award | A | $667 66 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Awsare SaleelDirector, President & CEO |  LTRXLANTRONIX INCOption exercise | M | — 156.8K sh | Nov 2, 2026 traded Nov 1, 2026 |
| 9 | Krosnowski Scott CarrollChief Financial Officer |  QMLSQumulusAI, Inc.Option exercise | M | $14K 4,740 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | 2018 Reed Dynasty Trust10% Owner |  ARHSArhaus, Inc.Derivative conversion | C | — 192.9K sh | Nov 2, 2026 traded Oct 29, 2026 |
| 9 | Cooper Diane L.Director |  SNEXStoneX Group Inc.Grant or award | A | — 164 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Wilson DarrenEVP & Pres, Retail & Payments |  VYXNCR Voyix CorpOption exercise | M | — 19.6K sh | Nov 2, 2026 traded Nov 1, 2026 |
| 9 | Mulhall Christopher M.VP - Chief Accounting Officer |  FTVFortive CorpOption exercise | M | — 5,504 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Gahan Patrick JosephDirector | QMLSQumulusAI, Inc. Option exercise | M | $601 182 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Salvia Investment GmbH10% Owner |  BBTXBambusa Therapeutics, Inc.Derivative conversion | C | — 3.14M sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Mulhall Christopher M.VP - Chief Accounting Officer | FTVFortive Corp Option exercise | M | — 5,027 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 37.4K sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Salvia Investment GmbH10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 160.9K sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Gahan Patrick JosephDirector | QMLSQumulusAI, Inc. Option exercise | M | — 182 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Boattini JenniferSR VP Legal/General Counsel |  JBHTHUNT J B TRANSPORT SERVICES INCOption exercise | M | — 427 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Alfred MichaelDirector |  OPENOpendoor Technologies Inc.Grant or award | A | — 45.3K sh | Nov 2, 2026 traded Oct 29, 2026 |
| 9 | Weakley MonicaDirector |  AGNTAGNT, Inc.Grant or award | A | $31.41 9 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Boattini JenniferSR VP Legal/General Counsel | JBHTHUNT J B TRANSPORT SERVICES INC Option exercise | M | — 434 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Hackman Jeffrey S.Director, Chief Executive Officer |  FENCFENNEC PHARMACEUTICALS INC.Grant or award | A | — 1,159 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 16.4K sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Krosnowski Scott CarrollChief Financial Officer | QMLSQumulusAI, Inc. Option exercise | M | — 33.3K sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Barnes Victor ChristopherDirector | SHENSHENANDOAH TELECOMMUNICATIONS CO/VA/ Grant or award | A | $817 80 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Mulhall Christopher M.VP - Chief Accounting Officer | FTVFortive Corp Option exercise | M | — 3,532 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | van Houte HansChief Financial Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,750 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Boattini JenniferSR VP Legal/General Counsel | JBHTHUNT J B TRANSPORT SERVICES INC Option exercise | M | — 434 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Boattini JenniferSR VP Legal/General Counsel | JBHTHUNT J B TRANSPORT SERVICES INC Tax withholding | F | $39K 177 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Boattini JenniferSR VP Legal/General Counsel | JBHTHUNT J B TRANSPORT SERVICES INC Tax withholding | F | $48K 219 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 94.0K sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 15.8K sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | van Houte HansChief Financial Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,573 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | van Houte HansChief Financial Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,573 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Grant or award | A | — 100.0K sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Mulhall Christopher M.VP - Chief Accounting Officer | FTVFortive Corp Option exercise | M | — 1,017 sh | Nov 2, 2026 traded Oct 30, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K